Purpose: Previously, we developed breast cancer BRCA1-like and BRCA2-like copy-number profile shrunken centroid classifiers predictive for mutation status and response to therapy, targeting homologous recombination deficiency (HRD). Therefore, we investigated BRCA1- and BRCA2-like classification in ovarian cancer, aiming to acquire classifiers with similar properties as those in breast cancer. Experimental Design: We analyzed DNA copy-number profiles of germline BRCA1- and BRCA2-mutant ovarian cancers and control tumors and observed that existing breast cancer classifiers did not sufficiently predict mutation status. Hence, we trained new shrunken centroid classifiers on this set and validated them in the independent The Cancer Genome Atlas...
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their ...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their ...
Purpose: Previously, we developed breast cancer BRCA1-like and BRCA2-like copy-number profile shrunk...
. These authors contributed equally to this work. Detecting mutation in BRCA1/2 is a generally accep...
We evaluated homologous recombination deficient (HRD) phenotypes in epithelial ovarian cancer (EOC) ...
Contains fulltext : 153904.pdf (publisher's version ) (Open Access)Breast cancers ...
Abstract Background BRCA1-mutated cancers exhibit deficient homologous recombination (HR) DNA repair...
Inactivating mutations in BRCA1 or BRCA2 confer a large lifetime risk of breast and ovarian cancer. ...
In 70 % of the families with a high frequency of early-onset breast and/or ovarian cancer, BRCA1 or ...
The fulltext of this publication will be made publicly available after relevant embargo periods have...
Background: Germline BRCA1/2 mutations are identified in 13-15% of ovarian cancers, while an additio...
Aim: To identify the frequency of somatic BRCA mutation in epithelial ovarian cancer (EOC), particul...
Purpose: BRCA2 plays a central role in homologous recombination by loading RAD51 on DNA breaks. The ...
Introduction: BRCA-mutated breast cancer cells lack the DNA-repair mechanism homologous recombinatio...
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their ...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their ...
Purpose: Previously, we developed breast cancer BRCA1-like and BRCA2-like copy-number profile shrunk...
. These authors contributed equally to this work. Detecting mutation in BRCA1/2 is a generally accep...
We evaluated homologous recombination deficient (HRD) phenotypes in epithelial ovarian cancer (EOC) ...
Contains fulltext : 153904.pdf (publisher's version ) (Open Access)Breast cancers ...
Abstract Background BRCA1-mutated cancers exhibit deficient homologous recombination (HR) DNA repair...
Inactivating mutations in BRCA1 or BRCA2 confer a large lifetime risk of breast and ovarian cancer. ...
In 70 % of the families with a high frequency of early-onset breast and/or ovarian cancer, BRCA1 or ...
The fulltext of this publication will be made publicly available after relevant embargo periods have...
Background: Germline BRCA1/2 mutations are identified in 13-15% of ovarian cancers, while an additio...
Aim: To identify the frequency of somatic BRCA mutation in epithelial ovarian cancer (EOC), particul...
Purpose: BRCA2 plays a central role in homologous recombination by loading RAD51 on DNA breaks. The ...
Introduction: BRCA-mutated breast cancer cells lack the DNA-repair mechanism homologous recombinatio...
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their ...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their ...